Technology | September 28, 2011

CIVCO Focuses on Robotic Innovation and Motion Management at ASTRO 2011

CIVCO Focuses on Robotic Innovation and Motion Management at ASTRO 2011

September 28, 2011 – At ASTRO, Civco Medical Solutions will highlight the Protura Robotic Patient Positioning System and multiple motion management solutions, including the RFSuite RFID Tracking & Verification System.

Protura Robotic Patient Positioning System

Civco's Protura Robotic Patient Positioning System positions patients in 6 degrees of freedom with sub-millimeter accuracy. Knowing the demands of the clinic and the importance of patient safety, precision and accuracy were fundamental to the design of Protura. Civco's robotic system integrates with existing image-guided radiotherapy (IGRT) solutions and linear accelerators. There are currently 14 Proturas installed in four countries, with several more pending installations.

"As cancer centers continue to adopt more advanced imaging modalities, they gain the ability to visualize anatomy more precisely," said Eric Knipfer, Civco's director of business development for Protura. "By adding Protura, clinicians are able to take full advantage of the robotics platform by treating at sub-millimeter accuracy. We have seen the clinical advantages not just in [stereotactic body radiotherapy] SBRT cases but also in standard IMRT. I am excited to see the increases in accuracy and efficiency along with the improved clinical workflow robotics adds to these programs."  

Protura may assist with decreasing patient treatment times by allowing the therapist to reposition the patient without re-entering the treatment room. Protura is the ideal solution for streamlining throughput and enabling more accurate treatments.

RFSuite RFID Tracking & Verification System

The RFSuite system uses radio frequency identification (RFID) technology to track patients, staff and equipment and to provide accessory and patient identity verification for treatment. The RFSuite software, RFTrak, provides a snapshot of where people and items are located in a facility in real time, improving workflow by eliminating time wasted looking for misplaced treatment accessories and reducing patient wait time. Civco's RFSeries line provides a broad array of RFID-enabled positioning products.

"RFSuite and other innovative Civco solutions are providing the clinical community with today's tools needed to enhance safety and ensure the effective delivery of radiation therapy," said Geoffrey Dalbow, chief technology officer for Civco.  "We are collecting compelling clinical data on the use of RFID technologies to reduce errors and improve radiation oncology workflow at both Moores Cancer Center in San Diego, Calif., and Hospital San Raffaele in Milan, Italy." RFSuite represents the macro component of Civco's motion management symposium.

New Horizon Prone Breastboard

Civco's New Horizon Prone Breastboard assists in providing comfortable, reproducible patient positioning for prone breast treatments. The modular design and a variety of accessories allow clinicians to customize patient setups, including overall height adjustments. The indexable New Horizon features a height adjustable, indexable prone face cushion as well as indexable hand placement, including asymmetrical options for patient comfort.  The treatment opening is past midline for medial field edge visualization, and a variety of wedges are available for the contralateral breast to assist in proper patient positioning. The bridge attachment option offers the use of a Clam-Lok Cushion and Laser-Lok.

For more information: www.civco.com

Related Content

News | Breast Imaging | September 20, 2021
September 20, 2021 — ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of...
This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of TriVu ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
While the Mammography Quality Standards Act (MQSA) and the introduction of EQUIP (Enhancing Quality Using the Inspection Program) have been successful in standardizing and enhancing mammographic imaging quality, inadequate breast positioning can dramatically impact the ability of radiologists and technicians to quickly and accurately detect breast cancer and potentially malignant lesions in their patients

Getty Images

Feature | Mammography | September 15, 2021 | By Christopher Austin, M.D. and Randy D. Hicks, M.D., MBA
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
According to ARRS’ American Journal of Roentgenology (AJR), immediately reading screening mammograms during the coronavirus disease (COVID-19) pandemic promises a new and improved paradigm—reducing care disparities, while increasing the speed of diagnostic workup.

Flow Chart of Patient Selection

News | Breast Imaging | September 09, 2021
September 9, 202
Laws designed to help women with increased risk for missed breast cancer diagnoses may help catch the disease earlier, according to Penn State College of Medicine researchers.

Getty Images | AleksandarNakic

News | Breast Imaging | September 09, 2021
September 9, 2021 — Laws designed to help women with increased risk for...
The researchers say there is currently a lack of good quality evidence to support a policy of replacing human radiologists with artificial intelligence (AI) technology when screening for breast cancer.

Getty Images

News | Artificial Intelligence | September 02, 2021
September 2, 2021 — Humans still seem to be better than technology when it comes to the accuracy of spotting possible
Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy to treat breast cancer, researchers are now exploring the potential integration of CDK inhibitors with radiotherapy

Schematic overview of cell cycle regulation, with an emphasis on radiotherapy-induced pathways and CDK/cyclin regulation. In M phase and in G2 resting phase, cancer cells are respectively very sensitive and moderately sensitive to radiation injury, whereas in G1 phase and in S phase, cancer cells are moderately resistant to radiation injury. Irradiation induces G1 and G2 cell cycle checkpoint activation and DNA repair. Most cancer cells are defective in G1 checkpoint, commonly due to the mutations/alterations of the key regulators of the G1 checkpoint, but contain a functional G2 checkpoint. Figure courtesy of The International Journal of Molecular Sciences

News | Radiation Therapy | August 18, 2021
August 18, 2021 — Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy t